# Aptinyx Inc.: Form D filings

Aptinyx Inc., a pharmaceuticals company in Evanston, IL, filed 2 Form D notices with the SEC between 2016 and 2017. The latest, on December 21, 2017, reports $70 million sold of a $70 million offering to 63 investors.

Find out what Aptinyx Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Aptinyx%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Aptinyx%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Faptinyx-inc-1674365)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Aptinyx%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Aptinyx%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Faptinyx-inc-1674365)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Illinois](https://specstream.ai/data/form-d/state/illinois): 1,511 rows, by operating companies, filed since November 1, 2024, $75.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/illinois
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1801 MAPLE AVENUE, SUITE 4300, Evanston, IL, 60201
- Phone: (847) 871-0377
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2015
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1674365

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 21, 2017 | New notice | $70,000,000 | $70,000,000 | $0 | 63 | Dec 15, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1674365/000167436517000001/0001674365-17-000001-index.htm) |
| May 19, 2016 | New notice | $65,000,000 | $24,999,999 | $40,000,001 | 48 | May 4, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1674365/000167436516000001/0001674365-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joseph R. Moskal | Executive Officer |  |
| Terry P. Gould | Director |  |
| Andrew D. Kidd | Executive Officer |  |
| James P. Topper | Director |  |
| Ashish M. Khanna | Executive Officer |  |
| Torsten M. Madsen | Executive Officer |  |
| Liam P. Ratcliffe | Director |  |
| Adam M. Koppel | Director |  |
| Wilbur H. Gantz III | Director |  |
| Norbert G. Riedel | Executive Officer, Director |  |
| Patrick H. Enright | Director |  |

[Every Form D from the week of Dec 18, 2017](https://specstream.ai/data/form-d/week/2017-12-18) · [All recent filings in Illinois](https://specstream.ai/data/form-d/state/illinois) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Aptinyx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).